Trial Profile
Pegaspargase-based concurrent chemoradiotherapy in the treatment of stage I/II extranodal NK/T cell lymphoma: a single center, single arm, phase 2 clinical trial.
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 Apr 2016
Price :
$35
*
At a glance
- Drugs Pegaspargase (Primary)
- Indications Extranodal NK-T-cell lymphoma
- Focus Therapeutic Use
- 28 Apr 2016 New trial record